Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
36
Number of overlapping holdings
27.7%
% of XBI's 131 holdings also in BBP
69.2%
% of BBP's 55 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
ROIVANT SCIENCES LTD. | 1.2% | 1.9% | 1.2% |
 |
EXELIXIS INC | 1.1% | 1.7% | 1.1% |
|
ALNYLAM PHARMACEUTICALS INC | 1.1% | 1.5% | 1.1% |
|
SAREPTA THERAPEUTICS INC | 1.1% | 2.4% | 1.1% |
|
BIOMARIN PHARMACEUTICAL INC | 1.1% | 1.6% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to BBP
|
EXACT SCIENCES CORP | 1.2% |
|
CRINETICS PHARMACEUTICALS INC | 1.2% |
|
CYTOKINETICS INC | 1.2% |
|
NATERA INC | 1.2% |
|
VIKING THERAPEUTICS, INC. | 1.1% |
|
KRYSTAL BIOTECH, INC. | 1.1% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | 1.1% |
|
ARCUTIS BIOTHERAPEUTICS INC | 1.1% |
|
DYNE THERAPEUTICS INC | 1.1% |
|
IMMUNOVANT INC | 1.1% |
XBI Underweight Relative to BBP
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
LEXICON PHARMACEUTICALS, INC. | -3.4% |
|
ASCENDIS PHARMA A/S | -2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.3% |
|
LIGAND PHARMACEUTICALS-CL B | -2.1% |
|
AXSOME THERAPEUTICS, INC. | -2.0% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | -2.0% |
|
INTRA-CELLULAR THERAPIES INC | -2.0% |
|
ADMA BIOLOGICS, INC. | -1.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -1.9% |